Menu
GeneBe

15-26883178-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP2BP4

The NM_000810.4(GABRA5):c.221A>G(p.Gln74Arg) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q74K) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)

Consequence

GABRA5
NM_000810.4 missense

Scores

1
3
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.08
Variant links:
Genes affected
GABRA5 (HGNC:4079): (gamma-aminobutyric acid type A receptor subunit alpha5) GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. Transcript variants utilizing three different alternative non-coding first exons have been described. [provided by RefSeq, Jul 2008]
GABRB3 (HGNC:4083): (gamma-aminobutyric acid type A receptor subunit beta3) This gene encodes a member of the ligand-gated ionic channel family. The encoded protein is one the subunits of a multi-subunit chloride channel that serves as the receptor for gamma-aminobutyric acid, a major inhibitory neurotransmitter of the mammalian nervous system. This gene is located on the long arm of chromosome 15 in a cluster with two other genes encoding related subunits of the family. This gene may be associated with the pathogenesis of several disorders including Angelman syndrome, Prader-Willi syndrome, nonsyndromic orofacial clefts, epilepsy and autism. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, GABRA5
BP4
Computational evidence support a benign effect (MetaRNN=0.39733297).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GABRA5NM_000810.4 linkuse as main transcriptc.221A>G p.Gln74Arg missense_variant 5/11 ENST00000335625.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GABRA5ENST00000335625.10 linkuse as main transcriptc.221A>G p.Gln74Arg missense_variant 5/111 NM_000810.4 P1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 03, 2021The c.221A>G (p.Q74R) alteration is located in exon 5 (coding exon 3) of the GABRA5 gene. This alteration results from a A to G substitution at nucleotide position 221, causing the glutamine (Q) at amino acid position 74 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Uncertain
0.031
T
BayesDel_noAF
Benign
-0.19
Cadd
Benign
23
Dann
Uncertain
0.99
DEOGEN2
Benign
0.25
T;T;T;T;.;.;.;.
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.036
FATHMM_MKL
Pathogenic
0.98
D
M_CAP
Benign
0.065
D
MetaRNN
Benign
0.40
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.84
T
MutationAssessor
Benign
0.090
N;N;.;N;.;.;.;.
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-1.6
N;N;N;N;N;N;N;N
REVEL
Benign
0.25
Sift
Benign
0.14
T;T;T;T;D;T;T;T
Sift4G
Benign
0.40
T;T;T;T;D;T;T;T
Polyphen
0.019
B;B;.;B;.;.;.;.
Vest4
0.54
MutPred
0.32
Gain of phosphorylation at T77 (P = 0.0794);Gain of phosphorylation at T77 (P = 0.0794);.;Gain of phosphorylation at T77 (P = 0.0794);Gain of phosphorylation at T77 (P = 0.0794);Gain of phosphorylation at T77 (P = 0.0794);Gain of phosphorylation at T77 (P = 0.0794);.;
MVP
0.79
MPC
1.1
ClinPred
0.92
D
GERP RS
4.3
Varity_R
0.16
gMVP
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr15-27128325; API